Anti-Cancer Drugs Flashcards
purine inhibitors
6-mercaptopurine, azathioprine, pentostatin, cladribine
6-mercaptopurine, azathioprine
-MOA: converted to T-IMP by hypoxanthine-guanine phosphoribosyltransferase (HGPRT); T-IMP inhibits IMPDH => decreased intracellular AMP and GMP; inhibits purine synthesis
-AE: myelosuppression, hepatoxicity, uricemia, GI upset, rash
pentostatin
-MOA: inhibits adenosine deaminase and homocysteine hydrolase => increased homocysteine (toxic to lymphocytes)
-AE: myelosuppression, nephro/neurotoxicity
cladribine
-MOA: incorporates into DNA causing strand breakage; depletes pools of NAD and ATP
pyrimidine inhibitors
cytarabine, gemcitabine, 5-fluorouracil, capecitabine (prodrug)
cytarabine
-MOA: inhibits DNA polymerase by competing with CTP for binding => chain termination
-AE: myelosuppression, ulceration of GI mucosa, nausea/vomiting
gemcitabine
-MOA: competitively inhibits DNA polymerase in inhibits DNA chain elongation
-AE: nausea, vomiting, flu-like symptoms
5-fluorouracil, capecitabine
-MOA: converted to FdUMP => inhibits thymidylate synthase => thymine depletion => FdUTP incorporates into DNA
-AE: myelosuppression, cardiotoxicity, GI ulcers, alopecia, thymine depletion, CNS/visual alterations, hand-foot syndrome, Steven-Johnson syndrome (capecitabine)
folate analogues
methotrexate
MOA: inhibits thymidylate synthase and dihydrofolate reductase (DHFR), preventing DNA synthesis
AE: myelosuppression, folate deficiency*, thymine depletion, mouth ulcers, nephro/hepatotoxic, pulmonary fibrosis, teratogenic
*leucovorin (folinic acid) nonenzymatically generates THFs - protects/rescues normal cells from folate deficiency
taxanes
paclitaxel, docetazel
MOA: bind beta-tubulin, inhibiting depolymerization
AE: myelosuppression (docetaxel), neuropathy (paclitazel), mucositis, tumor lysis syndrome
vinca alkaloids
vincristine, vinblastine
MOA: bind beta-tubulin, inhibiting polymerization
AE:
neurotoxicity (vincristine), myelosuppression (vinblastine), alopecia, nausea/vomiting
topoisomerase inhibitors
topotecan, irinotecan, etoposide
topotecan, irinotecan
-MOA: inhibits topoisomerase I
-AE: myelosuppression, diarrhea
etocposide
-MOA: inhibits topoisomerase II
-AE: myelosuppression, alopecia, tumor lysis syndrome*
*rasburicase metabolizes uric acid produced by TLS
hydroxyurea
MOA: binds iron and tyrosine radical at ribonucleotide reductase so it cannot convert nucleotides to deoxynucleotides => inhibits DNA synthesis
AE: severe myelosuppression, megaloblastic anemia
bleomycin
MOA: generates free radicals due to iron/oxygen interaction, causing strand breakage
AE: pulmonary fibrosis, alopecia, stomatitis
cytotoxic antibiotics
dactinomycin (actinomycin D)
MOA: binds DNA between G-C residues and inhibits topoisomerase II and RNA polymerase binding
AE: myelosuppression
anthracyclines
doxorubicin (hydroxydaunorubicin), daunorubicin
MOA: generates free radicals; DNA binding and strand breakage; topoisomerase II inhibition
AE: myelosuppression, alopecia, cardiomyopathy*
*dexrazoxane inhibits free radical formation, decreasing cardiomyopathy
triazenes
decarbazine/ temozolomide, procabazine
MOA: DNA methylation leads to strand breakage; generation of peroxide radicals leads to cellular toxicity
AE: myelosuppression, nausea/ vomiting
nitrogen mustards
cyclophosphamide, isosfamide, carmustine, lomustine
cyclophosphamide, isosfamide
-MOA: immunosuppressive and dose-dependent cross-linking of DNA strands
-AE: hemorrhagic cystitis, infertility, embryo toxicity, myelosuppression
carmustine, lomustine
-MOA: C-G cross-linking and RNA/RNA cross-linking
-AE: CNS toxicity (dizziness, ataxia, seizures), infertility, myelosuppression
platinums
cisplatin, carboplatin, oxaplatin
MOA: platinum binds two bases causing DNA cross-linking
AE: neuropathy, Faconi syndrome (nephrotoxicity), myelosuppression, nausea
cyclophosphamide and isosfamide are administered with [?]
mesna
binds to and inactivates toxic metabolite acrolein
sulfonates
busulfan
MOA: cross-links DNA via G-A bases
AE: severe myelosuppression, pulmonary fibrosis, skin hyperpigmentation